Abstract：
Depression is undertreated in patients with chronic kidney disease (CKD) stage 4 without kidney replacement therapy (KRT), despite evidence showing its association with an increase in morbidity and mortality. Earlier and more adequate identification of patients with depression is needed. A quasi-experimental evidence-based project included 33 patients with CKD stage 4 not on KRT from a local nephrology office. The patients, who had previously been screened with the Patient Health Questionnaire-2 (PHQ-2), were screened with the Beck Depression Inventory. Nine patients (27%) had Beck Depression Inventory scores suggesting the need for a mental health referral compared to none having the need for a mental health referral captured by the PHQ-2. Results of this study indicate that screening with the Beck Depression Inventory should be considered to more accurately identify patients with depressive symptoms so interventions can occur earlier.
摘要：
慢性肾脏病（CKD）第4期患者未接受肾脏替代疗法（KRT）的抑郁症治疗不足，尽管有证据表明其与发病率和死亡率的增加有关。需要更早和更充分地识别抑郁症患者。一项基于准实验证据的项目包括33名CKD4期患者，该患者未从当地肾脏病办公室接受KRT治疗。病人,以前用患者健康问卷-2(PHQ-2)筛查过的人，用贝克抑郁量表进行了筛选。9名患者（27％）的贝克抑郁量表得分表明需要进行心理健康转诊，而PHQ-2捕获的患者则没有需要进行心理健康转诊。这项研究的结果表明，应考虑使用贝克抑郁量表进行筛查，以更准确地识别患有抑郁症状的患者，从而可以更早地进行干预。
